Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 34 - Minutes of Proceedings - March 20, 2013

OTTAWA, Wednesday, March 20, 2013
(76)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:14 p.m., in room 2, Victoria Building, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Cordy, Eaton, Enverga, Martin, Mercer, Munson, Ogilvie, Seidman, Seth and Verner, P.C. (10).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Tuesday, November 22, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

Rx&D:

Walter Robinson, Vice President, Government Relations;

Jared Rhines, Scientific and Regulatory Affairs.

BIOTECanada:

Andrew Casey, President and Chief Executive Officer.

Canadian Generic Pharmaceutical Association:

David Windross, Vice-President of External Relations, Teva Canada.

The chair made a statement.

Mr. Casey, Mr. Robinson and Mr. Windross each made a statement and, together with Mr. Rhines, answered questions.

At 5:40 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee